rs200857990
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The NM_015459.5(ATL3):āc.2T>Cā(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000272 in 1,583,206 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000046 ( 0 hom., cov: 32)
Exomes š: 0.000025 ( 0 hom. )
Consequence
ATL3
NM_015459.5 start_lost
NM_015459.5 start_lost
Scores
4
5
7
Clinical Significance
Conservation
PhyloP100: 2.81
Genes affected
ATL3 (HGNC:24526): (atlastin GTPase 3) This gene encodes a member of a family of dynamin-like, integral membrane GTPases. The encoded protein is required for the proper formation of the network of interconnected tubules of the endoplasmic reticulum. Mutations in this gene may be associated with hereditary sensory neuropathy type IF. Alternatively spliced transcript variants that encode distinct isoforms have been described. [provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Start lost variant, no new inframe start found.
BS2
High AC in GnomAd4 at 7 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATL3 | NM_015459.5 | c.2T>C | p.Met1? | start_lost | 1/13 | ENST00000398868.8 | NP_056274.3 | |
ATL3 | XM_006718493.2 | c.2T>C | p.Met1? | start_lost | 1/12 | XP_006718556.1 | ||
ATL3 | XM_047426725.1 | c.158T>C | p.Met53Thr | missense_variant | 2/14 | XP_047282681.1 | ||
ATL3 | NM_001290048.2 | c.-9+302T>C | intron_variant | NP_001276977.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATL3 | ENST00000398868.8 | c.2T>C | p.Met1? | start_lost | 1/13 | 1 | NM_015459.5 | ENSP00000381844 | ||
ATL3 | ENST00000540699.1 | c.158T>C | p.Met53Thr | missense_variant | 2/4 | 3 | ENSP00000441842 | |||
ATL3 | ENST00000538786.1 | c.-9+302T>C | intron_variant | 2 | ENSP00000437593 | P1 | ||||
ATL3 | ENST00000535789.1 | n.413T>C | non_coding_transcript_exon_variant | 1/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152072Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
7
AN:
152072
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000252 AC: 36AN: 1431016Hom.: 0 Cov.: 31 AF XY: 0.0000253 AC XY: 18AN XY: 711140
GnomAD4 exome
AF:
AC:
36
AN:
1431016
Hom.:
Cov.:
31
AF XY:
AC XY:
18
AN XY:
711140
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74440
GnomAD4 genome
AF:
AC:
7
AN:
152190
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neuropathy, hereditary sensory, type 1F Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 08, 2018 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change affects the initiator methionine of the ATL3 mRNA. The next in-frame methionine is located at codon 19. This variant is present in population databases (rs200857990, ExAC 0.02%). This variant has not been reported in the literature in individuals with ATL3-related disease. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in ATL3 cause disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;T
M_CAP
Pathogenic
D
MetaRNN
Uncertain
T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;N
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Pathogenic
D;T
Sift4G
Benign
T;.
Polyphen
B;P
Vest4
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at